Abstract B23: <i>FGFR3</i> mutations and their relation to FGFR3 expression and clinical outcome in a large radical cystectomy cohort: Implications for anti-FGFR3 bladder cancer treatment?
Bas van Rhijn(The Netherlands Cancer Institute), Tahlita C.M. Zuiverloon(Erasmus MC), Alexandre R. Zlotta(University of Toronto), Michael A.S. Jewett(Princess Margaret Cancer Centre), S. A. Gotz(University of Regensburg), Yanish Soorojebally(Université de Versailles Saint-Quentin-en-Yvelines), Deric van der Schoot(Amphia Ziekenhuis), Núria Malats(Spanish National Cancer Research Centre), Ellen C. Zwarthoff(Erasmus MC), Wolfgang Otto(University of Regensburg), Arndt Hartmann(Universitätsklinikum Erlangen), Mirari Marques, Theodorus van der Kwast(Erasmus MC), Francisco X. Real(Universitat Pompeu Fabra), Damien Pouessel(Institut Claudius Regaud), Markus Eckstein(Friedrich-Alexander-Universität Erlangen-Nürnberg), François Radvanyi(Centre National de la Recherche Scientifique), Peter J. Boström(University of Turku), Yves Allory(Institut Curie), Robert Stöhr(Friedrich-Alexander-Universität Erlangen-Nürnberg), Geert van Leenders, Max M. Burger(Radboud University Nijmegen), Roman Mayr(Ospedale di Bolzano), Laura S. Mertens(Oncode Institute)
Cited by 0
Related Papers
A Consensus Molecular Classification of Muscle-invasive Bladder Cancer
|European Urology|2019|1.4k
External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study
|The Lancet Oncology|2010|944
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy
|European Urology|2017|798
The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma
|The American Journal of Surgical Pathology|2020|705
Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes
|European Urology|2015|688